PATENT FORMULATION COMMERCIALIZATION AGREEMENT BETWEEN DROGSAN PHARMACEUTICALS AND CUMHURIYET UNIVERSITY
Drogsan led the way again. First time in Turkey, a patent formulation developed by a medical faculty was brought into use by a domestic company. “ Storice” containing Strontium+Licorice and developed by Members of Sivas Cumhuriyet University Medical Faculty Department of Dermatology was turned into a commercial product and brought to the health sector by Drogsan Pharmaceuticals.
“Patent Formulation Commercialization Agreement” was signed between Cumhuriyet University and Drogsan Pharmaceuticals in the organization of University Presidency. President Prof. Dr. Alim YILDIZ has presented appreciation plaques to TMMDA V.P. Recep USLU, Head of Medical Devices and Cosmetic Yücel DENER, Drogsan Pharmaceuticals CEO Mustafa KARPUZCU, Drogsan Pharmaceuticals General Manager Dr. Ersan KÜÇÜK, Sivas Cumhuriyet University Department of Dermatology Faculty Member Prof. Dr. Melih AKYOL, and Technopolis Manager Dr. Serdar MERCAN.